Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04661449

Effects of Lifestyle Intervention on Childhood Outcomes in LGA Infants

Childhood Health Outcomes in Term, Large-for-gestational-age Infants: Effects of Lifestyle Intervention in the Postnatal First Year

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
138 (estimated)
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
1 Day – 1 Month
Healthy volunteers
Not accepted

Summary

Large-for-gestational-age (LGA) infants have a higher risk of metabolic disease later in life, and their postnatal growth in early childhood may be associated with long-term adverse outcomes. The purpose of this study is to explore whether comprehensive lifestyle intervention in the first year after birth in LGA infants will reduce the rate of overweight/obesity at childhood and improve neurodevelopmental outcomes and its possible mechanism.

Detailed description

Term LGA infants will be randomly divided into two groups shortly after birth: intervention group and control group. Infants in intervention group will attend the follow-up clinic and motor development assessment and guidance will be provided every three months in the first year. Other lifestyle interventions include feeding guidance and healthcare education. Infants in control group will routinely attend the follow-up clinic every six months. Primary outcome is the rate of overweight/obesity at two years old and seven years old. Neurodevelopmental assessment, carotid intima-media thickness (CIMT) and blood pressure at childhood will also be evaluated. The association of the outcome of LGA infants at two years old and the biomarkers in cord blood will be investigated, which includes serum leptin, insulin, insulin-like growth factors -1 (IGF-1), blood lipid series and adiponectin.

Conditions

Interventions

TypeNameDescription
OTHERComprehensive lifestyle interventionFeeding guidance: promoting exclusive breastfeeding and healthy diet (Pediatrician). Motor development assessment and guidance: Alberta Infant movement scale (AIMS) evaluation, guidance for motor development (Rehabilitation Therapist). Healthcare education: improvement of environmental exposure (Pediatrician).

Timeline

Start date
2021-01-22
Primary completion
2023-11-30
Completion
2029-11-30
First posted
2020-12-10
Last updated
2021-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04661449. Inclusion in this directory is not an endorsement.